Metildigoxin market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing incidence of heart disease across the globe due to unhealthy eating habits, sedentary lifestyles, and many others. According to NHANES, in 2018, the prevalence of CVD was around 49.2% that will fuel the growth of the market during the forecast period.
Metildigoxin is used for the treatment of acute and chronic heart failure and cardiac arrhythmia. It is a semisynthetic cardiac glycoside that is converted into digoxin after oral administration. The injectable form of the drug is administered by slow intravenous infusion and the dose is tailored according to each individual and the severity of the disease. With the increasing prevalence of CVD due to factors like smoking, pollution, stress, and many others it is estimated that the demand will grow for the metildigoxin during the forecast period.
The drug Metildigoxin is also used for the treatment of congestive heart failures in the dog, as well as many other heart conditions. The drug may go by the brand name of Cardoxin or Lanoxin for the treatment in dogs. The function of the drug in dogs is by increasing the level of calcium in the heart, which helps in muscle contraction. This strengthens the heartbeat, increases the amount of blood flow and reduces the fluid build up in the lungs. The drug is also used for various other conditions such as atrial fibrillation, cardiac arrhythmias, and many others in dogs. With the increasing adoption of pets across the globe, this factor will fuel the growth of the market during the forecast period. Some of the key global players in the global metildigoxin market include Centroflora, Tianjin Kaiwei and Young United Chemical, Kemprotec, and many others.
To Request a Sample of our Report on Metildigoxin Market: https://www.omrglobal.com/request-sample/metildigoxin-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions Covered
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape –Centroflora, Tianjin Kaiwei and Young United Chemical, Kemprotec.
Metildigoxin Market by Segments
By Type
- Tablet
- Injection
- Other
By Application
- Cardiac
- Other
A full Report of Metildigoxin Market is Available at: https://www.omrglobal.com/industry-reports/metildigoxin-market
Metildigoxin Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
